Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2

BMC Biochemistry

Volumn 11, Issue 1, 2010, Pages

  Wang, Ping ^a   Jiang, Yong ^a   Wang, Yinsheng ^a   Shyy, John Y ^a   DeFea, Kathryn A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; BETA ARRESTIN 2; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE BETA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEINASE ACTIVATED RECEPTOR 2; UNCLASSIFIED DRUG; AMP ACTIVATED PROTEIN KINASE KINASE; AMP-ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE; RECOMBINANT PROTEIN; RETINA S ANTIGEN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL ENERGY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENERGY BALANCE; ENZYME ACTIVATION; ENZYME ASSAY; FIBROBLAST; LIVER; MOUSE; NONHUMAN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ANIMAL; CELL STRAIN 3T3; CHEMISTRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; ARRESTINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN KINASES; RECEPTOR, PAR-2; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 77956712828     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-11-36     Document Type: Article

References (46)

1. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. L Ge Y Ly M Hollenberg K DeFea, J Biol Chem 2003 278 34418 34426 10.1074/jbc.M300573200 12821670
2. Protease-activated-receptor-2 simultaneously directs beta-arrestin- dependent inhibition and Gaq-dependent activation of PI3K. P Wang K DeFea, Biochemistry 2006 45 9374 9385 10.1021/bi0602617 16878972
3. Differential regulation of Class IA Phosphatidylinositol 3-Kinase catalytic subunits p110a and by protease-activated-receptor-2 and β-arrestins. P Wang P Kumar C Wang K DeFea, Biochem J 2007 428 221 230
4. beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. M Zoudilova P Kumar L Ge P Wang GM Bokoch KA DeFea, J Biol Chem 2007 282 20634 20646 10.1074/jbc.M701391200 17500066
5. A protective role for protease-activated receptors in the airways. TM Cocks B Fong JM Chow GP Anderson AG Frauman RG Goldie, et al. Nature 1999 398 156 160 10.1038/18223 10086357
6. Proteinase-activated receptor-2: physiological and pathophysiological roles. AM Coelho V Ossovskaya NW Bunnett, Curr Med Chem Cardiovasc Hematol Agents 2003 1 61 72 10.2174/1568016033356715 15317291
7. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. KA DeFea J Zalevsky MS Thoma O Dery RD Mullins NW Bunnett, J Cell Biol 2000 148 1267 1281 10.1083/jcb.148.6.1267 10725339
8. beta-Arrestins and Cell Signaling. SM DeWire S Ahn RJ Lefkowitz SK Shenoy, Annual Review of Physiology 2007 69 483 510 10.1146/annurev.physiol.69. 022405.154749 17305471
9. Transduction of receptor signals by beta-arrestins. RJ Lefkowitz SK Shenoy, Science 2005 308 512 517 10.1126/science.1109237 15845844
10. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. O Dery CU Corvera M Steinhoff NW Bunnett, Am J Physiol 1998 274 1429 C1452 9696685
11. JJ McGuire M Saifeddine CR Triggle K Sun MD Hollenberg, 2-furoyl-LIGRLO-amide: A potent and selective Proteinase-Activated Receptor 2 (PAR-2) agonist. J Pharmacol Exp Ther 2004 309 1124 1131 10.1124/jpet.103.064584 14976230
12. beta-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation. MM Paing AB Stutts TA Kohout RJ Lefkowitz J Trejo, J Biol Chem 2002 277 1292 1300 10.1074/jbc.M109160200 11694535
13. alpha-Thrombin Induces Rapid and Sustained Akt Phosphorylation by beta-Arrestin1-dependent and -independent Mechanisms, and Only the Sustained Akt Phosphorylation Is Essential for G1 Phase Progression. R Goel PJ Phillips-Mason DM Raben JJ Baldassare, J Biol Chem 2002 277 18640 10.1074/jbc.M108995200 11901145
14. Thrombin Activates AMP-Activated Protein Kinase in Endothelial Cells via a Pathway Involving Ca2+/Calmodulin-Dependent Protein Kinase Kinase {beta}. N Stahmann A Woods D Carling R Heller, Mol Cell Biol 2006 26 5933 5945 10.1128/MCB.00383-06 16880506
15. Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects With Type 2 Diabetes: A Time-Course and Dose-Response Study. A Sriwijitkamol DK Coletta E Wajcberg GB Balbontin SM Reyna J Barrientes, et al. Diabetes 2007 56 836 848 10.2337/db06-1119 17327455
16. Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores. M Rossmeisl P Flachs P Brauner J Sponarova O Matejkova T Prazak, et al. Int J Obes Relat Metab Disord 2004 28 Suppl 4 38 S44 10.1038/sj.ijo.0802855 15592485
17. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. GK Bandyopadhyay JG Yu J Ofrecio JM Olefsky, Diabetes 2006 55 2277 2285 10.2337/db06-0062 16873691
18. Activation of the AMP-Activated Kinase by Antidiabetes Drug Metformin Stimulates Nitric Oxide Synthesis In Vivo by Promoting the Association of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase. BJ Davis Z Xie B Viollet MH Zou, Diabetes 2006 55 496 505 10.2337/diabetes.55.02.06.db05-1064 16443786
19. AMP-Activated Protein Kinase as a Drug Target. DG Hardie, Annual Review of Pharmacology and Toxicology 2007 47 185 210 10.1146/annurev.pharmtox.47. 120505.105304 16879084
20. Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo. W Sun TS Lee M Zhu C Gu Y Wang Y Zhu, et al. Circulation 2006 114 2655 2662 10.1161/CIRCULATIONAHA.106.630194 17116771
21. Dissecting the Role of 5'-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase. M Suter U Riek R Tuerk U Schlattner T Wallimann D Neumann, J Biol Chem 2006 281 32207 32216 10.1074/jbc.M606357200 16943194
22. Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase. Y Wu P Song J Xu M Zhang MH Zou, J Biol Chem 2007 282 9777 9788 10.1074/jbc.M608310200 17255104
23. Cellular energy sensing and signaling by AMP-activated protein kinase. WW Winder DM Thomson, Cell Biochem Biophys 2007 47 332 347 10.1007/s12013-007- 0008-7 17652779
24. Chutes and Ladders: the search for protein kinases that act on AMPK. LA Witters BE Kemp AR Means, Trends in Biochemical Sciences 2006 31 13 16 10.1016/j.tibs.2005.11.009 16356723
25. Proteinase-activated receptors 1 and 2 in rat olfactory system: Layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons. MC Olianas S Dedoni P Onali, Neuroscience 2007 146 1289 1301 10.1016/j. neuroscience.2007.02.059 17434682
26. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. DG Hardie, Nat Rev Mol Cell Biol 2007 8 774 785 10.1038/nrm2249 17712357
27. LKB1 Kinase: Master and Commander of Metabolism and Polarity. J Spicer A Ashworth, Current Biology 2004 14 383 R385 10.1016/j.cub.2004.05.012 15186763
28. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. AF Baas J Boudeau GP Sapkota L Smit R Medema NA Morrice, et al. EMBO J 2003 22 3062 3072 10.1093/emboj/cdg292 12805220
29. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. TA Kohout FS Lin SJ Perry DA Conner RJ Lefkowitz, Proc Natl Acad Sci USA 2001 98 1601 1606 10.1073/pnas.041608198 11171997
30. Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. J Yang S Maika L Craddock JA King ZM Liu, Biochemical and Biophysical Research Communications 2008 370 248 253 10.1016/j.bbrc.2008.03.094 18381066
31. AMP-activated protein kinase (AMPK) is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. MS Gauthier H Miyoshi SC Souza JM Cacicedo AK Saha AS Greenberg, et al. J Biol Chem 2008 M708177200 18390901
32. beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. K DeFea, Br J Pharmacol 2007 18037927
33. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. L Stalheim Y Ding A Gullapalli MM Paing BL Wolfe DR Morris, et al. Mol Pharmacol 2005 67 78 87 10.1124/mol.104.006072 15475570
34. Functional specialization of beta-arrestin interactions revealed by proteomic analysis. K Xiao DB McClatchy AK Shukla Y Zhao M Chen SK Shenoy, et al. Proc Natl Acad Sci USA 2007 104 12011 12016 10.1073/pnas.0704849104 17620599
35. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its non-conserved N-terminus. C Guo AJ Whitmarsh, J Biol Chem 2008 M710006200
36. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. JM Beaulieu TD Sotnikova S Marion RJ Lefkowitz RR Gainetdinov MG Caron, Cell 2005 122 261 273 10.1016/j.cell.2005.05.012 16051150
37. beta-Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes. CJ Hupfeld S Dalle JM Olefsky, PNAS 2003 100 161 166 10.1073/pnas.0235674100 12509508
38. β-Adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, β-arrestin-2, and the ubiquitin-proteasome pathway. J Ogasawara M Sanpei N Rahman T Sakurai T Kizaki Y Hitomi, et al. FASEB J 2005 05-4688fje 16368719
39. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. B Luan J Zhao H Wu B Duan G Shu X Wang, et al. Nature 2009 457 1146 1149 10.1038/nature07617 19122674
40. Tumor Necrosis Factor Receptor-1 Can Function through a G{alpha}q/11-beta-Arrestin-1 Signaling Complex. Y Kawamata T Imamura JL Babendure JC Lu T Yoshizaki JM Olefsky, J Biol Chem 2007 282 28549 28556 10.1074/jbc.M705869200 17664271
41. Adipose tissue, adipokines, and inflammation. G Fantuzzi, J Allergy Clin Immunol 2005 115 911 919 10.1016/j.jaci.2005.02.023 15867843
42. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. CU Corvera O Dery K McConalogue SK Bohm LM Khitin GH Caughey, et al. J Clin Invest 1997 100 1383 1393 10.1172/JCI119658 9294103
43. Hemostatic response to postprandial lipemia before and after exercise training. CM Paton J Brandauer EP Weiss MD Brown FM Ivey SM Roth, et al. J Appl Physiol 2006 101 316 321 10.1152/japplphysiol.01363.2005 16497841
44. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. J Liu A Divoux J Sun J Zhang K Clement JN Glickman, et al. Nat Med 2009 15 940 945 10.1038/nm.1994 19633655
45. Integrative Metabolic Regulation of Peripheral Tissue Fatty Acid Oxidation by the Src Kinase Family Member Fyn. CC Bastie H Zong J Xu B Busa S Judex IJ Kurland, et al. Cell Metabolism 2007 5 371 381 10.1016/j.cmet.2007.04. 005 17488639
46. Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. GJ Cooney RJ Lyons AJ Crew TE Jensen JC Molero CJ Mitchell, et al. EMBO J 2004 23 582 593 10.1038/sj.emboj.7600082 14749734